NATALIZUMAB-SZTN for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where NATALIZUMAB-SZTN was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for NATALIZUMAB-SZTN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 63 | 33.5% | 0 | 3 |
| Mobility decreased | 52 | 27.7% | 0 | 0 |
| Balance disorder | 31 | 16.5% | 0 | 2 |
| Headache | 18 | 9.6% | 0 | 3 |
| Product substitution issue | 17 | 9.0% | 2 | 3 |
| Multiple sclerosis relapse | 16 | 8.5% | 0 | 1 |
| Muscular weakness | 16 | 8.5% | 0 | 0 |
| Cognitive disorder | 13 | 6.9% | 0 | 0 |
| Gait disturbance | 13 | 6.9% | 0 | 0 |
| Dizziness | 11 | 5.9% | 0 | 1 |
| Nausea | 9 | 4.8% | 0 | 0 |
| Urinary incontinence | 9 | 4.8% | 0 | 0 |
| Arthralgia | 7 | 3.7% | 0 | 2 |
| Dysphagia | 7 | 3.7% | 0 | 0 |
| Musculoskeletal stiffness | 7 | 3.7% | 0 | 2 |
Other Indications for NATALIZUMAB-SZTN
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)